📰 Alpn News
Page 6 - Alpn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpn. Real-time updates on events, politics, business and more.
March 27, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Oppenheimer issued their Q1 2024 earnings per share estimates for shares of Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Oppenheimer analyst M. Breidenbach expects that the biotechnology company will post earnings of ($0.41) per share for the quarter. The […]
March 27, 2023
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) had its price objective increased by HC Wainwright from $8.00 to $11.00 in a research report report published on Friday morning, The Fly reports. HC Wainwright also issued estimates for Alpine Immune Sciences’ Q2 2023 earnings at ($0.35) EPS and Q3 2023 earnings at ($0.39) EPS. Separately, Morgan […]
August 11, 2022
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $8.46 and traded as high as $8.94. Alpine Immune Sciences shares last traded at $8.80, with a volume of 60,111 shares changing hands. Analyst Upgrades and […]
July 8, 2022
CARTERVILLE, IL (WSIL) -- This edition of Job Squad features opportunities to work as a dispatcher, nurse, or retail manager.
June 29, 2022
Carmen Graham, LPN of Wartburg Senior Living and Healthcare, Wins Prestigious International Daisy Award
June 1, 2022
- ALPN-303 uniquely binds BAFF and APRIL with high affinity, differentiating from related inhibitors including wild-type TACI-Fc's - - Ongoing phase 1 study demonstrates highly encouraging preliminary
May 14, 2022
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.06), Fidelity Earnings reports. Alpine Immune Sciences had a negative net margin of 214.70% and a negative return on equity of 59.07%. […]
May 14, 2022
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) posted its quarterly earnings data on Thursday. The biotechnology company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.06), Fidelity Earnings reports. Alpine Immune Sciences had a negative return on equity of 59.07% and a negative net margin of 214.70%. NASDAQ […]
May 14, 2022
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.06), Fidelity Earnings reports. Alpine Immune Sciences had a negative return on equity of 59.07% and a negative net margin of 214.70%. NASDAQ:ALPN […]
April 13, 2022
Wall Street analysts expect that Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) will post sales of $13.35 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Alpine Immune Sciences’ earnings, with estimates ranging from $5.93 million to $20.00 million. Alpine Immune Sciences posted sales of $3.20 million in […]